Zacks Research Estimates Humana’s FY2024 Earnings (NYSE:HUM)

Humana Inc. (NYSE:HUM) – Investment analysts at Zacks Research lifted their FY2024 EPS estimates for Humana in a research report issued to clients and investors on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now anticipates that the insurance provider will post earnings per share of $16.04 for the year, up from their prior forecast of $16.01. The consensus estimate for Humana’s current full-year earnings is $15.83 per share. Zacks Research also issued estimates for Humana’s Q1 2025 earnings at $6.37 EPS and Q2 2025 earnings at $6.25 EPS.

Several other research analysts also recently commented on HUM. Truist Financial decreased their price objective on Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a report on Friday, October 11th. KeyCorp initiated coverage on Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Barclays raised their target price on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Wells Fargo & Company lowered their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Finally, Oppenheimer dropped their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus target price of $315.86.

Humana Stock Performance

Humana stock opened at $275.67 on Friday. The firm has a fifty day simple moving average of $283.00 and a two-hundred day simple moving average of $331.80. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana has a twelve month low of $213.31 and a twelve month high of $527.18. The company has a market capitalization of $33.19 billion, a PE ratio of 24.47, a P/E/G ratio of 2.29 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

Institutional Trading of Humana

Several institutional investors have recently bought and sold shares of the company. Pzena Investment Management LLC boosted its holdings in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after buying an additional 1,955,375 shares during the last quarter. Ontario Teachers Pension Plan Board boosted its stake in Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after purchasing an additional 1,050,459 shares during the period. Marshall Wace LLP boosted its position in shares of Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after acquiring an additional 774,085 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in shares of Humana by 261,025.1% during the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after purchasing an additional 738,701 shares during the last quarter. Finally, FMR LLC grew its holdings in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after buying an additional 643,291 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.